ClinicalTrials.govpublic full text
Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines
breast cancer, lymphoma, large b-cell, diffuse, cardiotoxicity, left ventricular dysfunction, chemotherapy effect, anthracycline chemotherapy, nebivolol, cardio-oncology, cancer therapy-related cardiovascular toxicity, cardiac magnetic resonance, primary prevention, cardioprotection
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 878365
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.